Neonatal Gaucher disease presenting as persistent thrombocytopenia

Journal of Perinatology

Volumn 25, Issue 5, 2005, Pages 356-358

  Roth, Philip ^a   Brooks, Susan Sklower ^b,c   Potaznik, Daniel ^a   Cooma, Ruby ^a   Sahdev, Shashi ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE;

ARTICLE; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; ENZYME REPLACEMENT; GAUCHER DISEASE; GENE MUTATION; HOMOZYGOSITY; HUMAN; HYPERBILIRUBINEMIA; INFANT; MALE; NEUROPATHY; SPLENOMEGALY; THROMBOCYTOPENIA;

ADULT; CESAREAN SECTION; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GAUCHER DISEASE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID; VITAMINS;

EID: 18444369963     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211262     Document Type: Article

References (11)

1. Mehta P, Vasa R, Neumann L, Karpatkin M. Thrombocytopenia in the high risk infant. J Pediatr 1980;97:791-4.
2. Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986;108:749-55.
3. Uhrynowska M, Maslanka K, Zupanska B. Neonatal thrombocytopenia: incidence, serological and clinical observations. Am J Perinatol 1997;14: 415-8.
4. Sola MC, Christensen RD. Developmental aspects of platelets and disorders in the neonatal period In: Christensen RD, editor. Hematologic Problems of the Neonate. Philadelphia, PA: WB Saunders; 2000. p. 273-309.
5. Wilcox WR. Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care. J Pediatr 2004;144:S3-14.
6. Kolodny EH, Charria-Ortiz G. Storage diseases of the reticuloendothelial system In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Hematology of infancy and Childhood. 6th ed. Philadelphia, PA: WB Saunders; 2003. P. 1399-454.
7. Grabowski GA. Gaucher disease: lessons from a decade of therapy. J Pediatr 2004;144:S15-9.
8. Filocam M, Mazzotti R, Stroppiano M, et al. Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian Gaucher patients. Hum Mutat 2002;20:234-5.
9. Michelakakis H, Skardoutsou A, Mathioudakis J, Dimitriou E, Voudiis C, Karpathios T. Early onset severe neurological involvement and D409H homozygosity in Gaucher disease: outcome of enzyme replacement therapy. Blood Cells Mol Dis 2002;28:1-4.
10. George R, Mcmahon J, Lytle B, Clark B, Lichtin k Severe valvalar and aortic arch calcification in a patient with Gaucher's disease homozygous for the D409H mutation. Clin Genet 2001;59:360-3.
11. Inui K, Yanagihara K, Otani K, et al. A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes and fibrous thickening of spleen and liver capsules. J Pediatr 2001;138:137-9.